Silver Book Fact

Every additional dollar spent on antiplatelet therapy versus aspirin for the prevention of stroke in high-risk patients, has produced health gains valued between $2 and $6.

MEDTAP International, Inc. The Value of Investment in Health Care: Better care, better lives. Bethesda, MD: MEDTAP; 2004. http://www.aha.org/content/00-10/08affordability-value.pdf

Reference

Title
The Value of Investment in Health Care: Better care, better lives
Publisher
MEDTAP
Publication Date
2004
Authors
MEDTAP International, Inc
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Economic Value

Related Facts

  • t-PA cost savings
    The total annual benefit to society from t-PA use in the United States is around $363 million—$60 million in direct cost savings to society plus an additional 7,510 QALYs. This means…  
  • Because of the advent of imaging and noninvasive testing, Americans who are asymptomatic are being diagnosed with established cardiovascular disease.  
  • Survival Rates of SAS Patients with and without SAVR
    Patients with severe aortic stenosis (SAS) ages 80+ who underwent surgical aortic valve replacement (SAVR) have 1-year, 2-year, and 5-year survival rates of 87%, 78%, and 68% respectively — compared with…  
  • Without antihypertensive drug therapy, there would have been about 572,000 more hospital discharges for stroke in 2002 and 261,000 more discharges for myocardial infarction.  
  • The rise in beta-blocker treatment rates (34% since 1996) is proof that sustained attention and effective initiatives saves lives and improves quality of life.